Pharma Journalist 8786 posts 0 comments

Boehringer Ingelheim announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies.…
Read More...

Consort Medical plc announces a significant new contract with Opiant Pharmaceuticals. Opiant is a specialty pharmaceutical company developing pharmacological treatments for addictions…
Read More...

EpimAb Biotherapeutics announced that it has filed an IND for its most advanced therapeutic development candidate EMB01. The applications were simultaneously submitted to the U.S. Food…
Read More...

Cambrex Corporation announced it has completed the acquisition of Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO) located in…
Read More...

Pall Corporation has announced a strategic partnership between its Pall Biotech business unit and Aetos Biologics, a biosimilar cell line development company. The companies will…
Read More...

SMi Group Reports: The official agenda and highlights for the 4th annual lyophilization USA Conference, which is taking place on the 15th and 16th November 2018 in Iselin, New Jersey,…
Read More...

Casma Therapeutics announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM), to develop new therapies for…
Read More...

Sherpa Clinical Packaging (Sherpa) has announced an agreement to be acquired by PCI Pharma Services (PCI). Sherpa, headquartered in San Diego, CA, provides clinical trial material…
Read More...

Portola Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Company’s Prior Approval Supplement (PAS) filing for the…
Read More...

WuXi Biologics and Inhibrx announced that the companies have entered into an exclusive partnership for the GMP manufacturing of certain of Inhibrx's protein-based therapeutics. The…
Read More...